Seaside Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$853K Buy
711
+6
+0.9% +$6.13K 0.21% 30
2026
Q1
$648K Buy
705
+7
+1% +$7.1K 0.18% 34
2025
Q4
$750K Buy
698
+7
+1% +$6.69K 0.21% 30
2025
Q3
$527K Hold
691
– – 0.16% 38
2025
Q2
$539K Buy
691
+26
+4% +$20.2K 0.17% 37
2025
Q1
$549K Buy
665
+15
+2% +$12.5K 0.2% 31
2024
Q4
$502K Hold
650
– – 0.18% 34
2024
Q3
$576K Hold
650
– – 0.22% 31
2024
Q2
$588K Buy
+650
New +$520K 0.24% 29

Other funds holding LLY

Seaside Wealth Management's LLY Position: Q2 2026 in Review

Seaside Wealth Management increased its Eli Lilly (LLY) stake by 0.85% in Q2 2026, buying an estimated $6.13K and bringing the position to 711 shares worth $853K. The position accounts for 0.21% of the portfolio, ranked #30.

Seaside Wealth Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Seaside Wealth Management held 711 shares of Eli Lilly worth $853K as of Q2 2026.
  • Seaside Wealth Management bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.21% of Seaside Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Seaside Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Seaside Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.